Last updated at 26 Jun 2024 06:01 PM
Director
DIN: 05265882
Satish Masilamani is currently associated with 3 companies as Director. They serve as a Director at IDEAL STUDIO WORKS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05265882.Satish Masilamani has previously been associated with 1 company in roles such as Additional Director.Satish Masilamani is currently involved in 1 different role. Their most recent position is with PEGASUS HEALTH PRIVATE LIMITED as a Director. The first company Satish Masilamani was appointed to as a director was IDEAL STUDIO WORKS PRIVATE LIMITED. Satish Masilamani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Satish Masilamani is currently associated with 3 companies as Director. They serve as a Director at IDEAL STUDIO WORKS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05265882.Satish Masilamani has previously been associated with 1 company in roles such as Additional Director.Satish Masilamani is currently involved in 1 different role. Their most recent position is with PEGASUS HEALTH PRIVATE LIMITED as a Director. The first company Satish Masilamani was appointed to as a director was IDEAL STUDIO WORKS PRIVATE LIMITED. Satish Masilamani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (1)
2y 9m 1y 5m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| IDEAL STUDIO WORKS PRIVATE LIMITED | Director | 15-May-2012 |
| IDEAL MARCOM WORKS PRIVATE LIMITED | Director | 01-Jun-2012 |
| PEGASUS HEALTH PRIVATE LIMITED | Director | 30-Sep-2022 |